404 related articles for article (PubMed ID: 10997497)
21. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
22. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
Kinghorn GR
Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
[TBL] [Abstract][Full Text] [Related]
23. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
24. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
26. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
27. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
[TBL] [Abstract][Full Text] [Related]
28. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
29. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.
Fiddian AP; Kinghorn GR; Goldmeier D; Rees E; Rodin P; Thin RN; de Konig GA
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():67-77. PubMed ID: 6355053
[TBL] [Abstract][Full Text] [Related]
30. Valacyclovir for the treatment of genital herpes.
Brantley JS; Hicks L; Sra K; Tyring SK
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study.
Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM
Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial.
Khemis A; Duteil L; Tillet Y; Dereure O; Ortonne JP
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1158-64. PubMed ID: 24010876
[TBL] [Abstract][Full Text] [Related]
33. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
Leone PA; Trottier S; Miller JM
Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
[TBL] [Abstract][Full Text] [Related]
34. Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group.
Lazarus HM; Belanger R; Candoni A; Aoun M; Jurewicz R; Marks L
Antimicrob Agents Chemother; 1999 May; 43(5):1192-7. PubMed ID: 10223935
[TBL] [Abstract][Full Text] [Related]
35. Genivir (DIP-253) 1% cream versus placebo cream in the treatment of recurrent genital herpes: a double-blind study.
Lassus A; Dahlgren A; Linnavuori K
Int J STD AIDS; 1990 Jan; 1(1):18-20. PubMed ID: 2099194
[TBL] [Abstract][Full Text] [Related]
36. A trial of topical acyclovir in genital herpes simplex virus infections.
Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
[TBL] [Abstract][Full Text] [Related]
38. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.
Corey L; Benedetti J; Critchlow C; Mertz G; Douglas J; Fife K; Fahnlander A; Remington ML; Winter C; Dragavon J
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():79-88. PubMed ID: 6355054
[TBL] [Abstract][Full Text] [Related]
39. Treatment of recurrent genital herpes simplex infections with oral acyclovir.
Ruhnek-Forsbeck M; Sandström E; Andersson B; Eriksson G; Hersle K; Lövhagen GB; Mobacken H; Hillström L; Svensson L
J Antimicrob Chemother; 1985 Nov; 16(5):621-8. PubMed ID: 3908435
[TBL] [Abstract][Full Text] [Related]
40. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
